Bioactive Technologies for Bone Replacement
Executive Summary
The global market for orthobiologics, comprised primarily of bone replacement materials, reached almost $2 billion in 2009 and is growing at an overall rate of 7%. Medtronic leads in bone replacement with a 45% market share, but overall growth in orthobiologics may come from emerging segments, particular synthetic and stem-cell based technologies.
You may also be interested in...
Cartilage Repair: The Next Wave in Orthopedics
The musculoskeletal sector continues to be bogged down by the economic downturn, and particularly hard hit is the industry’s largest segment: the $13 billion total joint market. Companies are now scouting out the next technology wave in orthopedics, and the record attendance at the recent International Cartilage Repair Society meeting may be one indication of where the action will be for some time to come.
Sports Medicine: The New Playing Field
Sports medicine is one segment of the device industry that may fare well in the post-health care reform world. New treatments aimed at preserving joint structures may protect young athletes from more invasive procedures down the road.
Medtronic Looks to Strengthen Spine with Osteotech Purchase
Medtronic, struggling to hold onto its sizable share of the shrinking spinal market, made a bid for publicly traded Osteotech, a maker of a demineralized bone matrix agent that will broaden the company's regenerative product portfolio.